Opu Labs Equity OfferingOffering
Bringing Trust to the $120 billion Skincare Industry
You are here
Page not found
Search results
IGF OncologyOffering
Develops targeted anti-cancer chemotherapy drugs with improved efficacy and lower side effects, currently in clinical trials at the Mayo Clinic.
Issuer Dealer And Agent Registration Requirements for Tier 2 OfferingsFAQ
to capital through the ability to raise up to $75 million, but also a greater ... provisions, hindering the issuer’s future capital raising activities. Alabama’s ...